Topical Pain Relief Program

The Topical Pain Relief Program is a patented OTC-ready formulation developed by CellMedics using the BIOAVAILANT® platform that enables targeted deep-tissue delivery of analgesic and anti-inflammatory compounds into muscle and joint structures.

Conventional topical pain creams are typically limited to superficial penetration, which can restrict the amount of active compound reaching underlying tissue. The BIOAVAILANT® platform is designed to enhance penetration beyond the skin barrier, supporting increased bioavailability within deeper tissue compartments where pain and inflammation originate.

By enabling delivery into muscle and joint tissue and increasing local concentrations of active compounds, the Topical Pain Relief Program is designed to improve functional efficacy compared to conventional topical formulations.

This program demonstrates the platform’s ability to support deep tissue delivery in real-world applications while maintaining a non-invasive, cream-based approach.

Highlights

  • Targeted delivery into muscle and joint tissue

  • Designed for enhanced deep tissue bioavailability

  • Supports analgesic and anti-inflammatory compounds

  • Needle-free, cream-based formulation

  • OTC-ready, market-ready program

Dermal Longevity Program

The Dermal Longevity Program is a patented OTC-ready topical formulation developed by CellMedics utilizing the BIOAVAILANT® platform to enable targeted delivery of peptides and bioactive compounds into epidermal and dermal tissue.

Conventional topical formulations are largely limited to the stratum corneum, resulting in minimal penetration and reduced functional activity. In contrast, the BIOAVAILANT® platform is designed to facilitate transport beyond the outer skin barrier, supporting increased bioavailability of active compounds within the epidermis and dermis where biological activity occurs.

By improving both depth of delivery and concentration of actives within target tissue, the Dermal Longevity Program is designed to enhance functional efficacy relative to conventional topical approaches.

This program reflects the application of advanced drug delivery principles to skin longevity, combining a needle-free, cream-based system with targeted dermal delivery.

Highlights

  • Targeted delivery into epidermal and dermal tissue

  • Designed to enhance bioavailability within skin layers where activity occurs

  • Supports delivery of peptides and bioactive compounds

  • Needle-free, cream-based formulation

  • OTC-ready, market-ready program